Valeo Pharma Inc
TSX:VPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valeo Pharma Inc
TSX:VPH
|
CA |
|
CSX Corp
NASDAQ:CSX
|
US |
|
Diebold Nixdorf Inc
F:DBDB
|
US |
|
S
|
Sasol Ltd
JSE:SOL
|
ZA |
|
O
|
OrganiGram Holdings Inc
NASDAQ:OGI
|
CA |
|
Washington H Soul Pattinson and Company Ltd
F:WD3
|
AU |
|
A
|
Atlantica Sustainable Infrastructure PLC
F:AY3
|
UK |
|
D
|
Dr Martens PLC
OTC:DRMTY
|
UK |
|
Hummingbird Resources PLC
LSE:HUM
|
UK |
|
Varun Beverages Ltd
NSE:VBL
|
IN |
|
D
|
DTE Energy Co
XMUN:DGY
|
US |
|
M
|
Manz AG
XMUN:M5Z
|
DE |
|
O
|
OFS Capital Corp
F:9UD
|
US |
|
Galderma Group AG
F:PY30
|
CH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VPH's stock price target?
Not Available
VPH does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Valeo Pharma Inc?
Projected CAGR
14%
Over the last 6 years, the compound annual growth rate for Revenue has been 87%. The projected CAGR for the next 2 years is 14%.